The Internet Journal of Anesthesiology

Questions and Answers

qa1.gif (5521 bytes)

by Olivier C. Wenker, M.D.

Part 11


Introduction: This site was created in order to stress your brain for a few minutes (3 questions) while surfing by. Every once in a while we will update this section with new questions and answers. This will give you the opportunity to check your knowledge in different anesthesiologic fields. If you would like to be informed whenever we update this section please subscribe for free as reader of  The Internet Journal of Anesthesiology.

Disclaimer: One should keep in mind that the current opinion in Europe may differ from the one in Australia or in the U.S. Having an international readership, it might be difficult to satisfy everybody with the given answers or the suggestions for additional reading. In order to assure the accuracy of this section, all the questions and especially the answers will be reviewed by several international members of the editorial board. Nevertheless, it is difficult to ensure that all the information given is entirely accurate for all circumstances. The publishers disclaim any liability, loss, or damage occurred as consequence, directly or indirectly, of the use and application of any of the content of this section.


Question 1:

What's wrong in this picture (besides that the patient is rotated) ?

cvc1a.jpg (8997 bytes)

 

for an answer click here

 


Question 2:

What is halothane hepatitis ?

 

 

 

for an answer click here

 


Question 3:

What is the difference between VCV and PCV in the ventilation of a patient ?

 

for an answer click here

 

 


 

 

 

 

 

 

 

 

Answers

Answer to Question 1:

The tip of the central venous catheter is in the left subclavian vein.

cvc1b.jpg (21514 bytes)

for next question (question 2) click here

 

 


 

 

 

 

 

 

 

Answer to Question 2:

Fulminant hepatic necrosis following halothane anesthesia (halothane hepatitis) occurs in one of 6,000 to 35,000 cases and is often fatal. Halothane hepatitis is probably caused by trifluoroacetyl-containing metabolites binding to protein and subsequently forming anti- trifluoroacetyl protein antibodies. During re-exposure of the patient with halothane these antibodies may mediate massive hepatic necrosis. Other agents such as enflurane, isoflurane and desflurane has been associated with immune based hepatitis. Because the metabolism of enflurane, isoflurane or desflurane is much less than the one of halothane, fulminant hepatic necrosis occurs to a much lesser extent. Sevoflurane does not form such proteins and does therefore not cause hepatic toxicity.


To learn more about Inhalation anesthetics please go to:
Wenker O: Review of Currently Used Inhalation Anesthetics; Part I. The Internet Journal of Anesthesiology 1999; Vol3N2: http://www.ispub.com/journals/IJA/Vol3N2/inhal1.htm; Published
April 1, 1999; Last Updated April 1, 1999.

 

for next question (question 3) click here

 

 


 

 

 

 

 

 

 

Answer to Question 3:

VCV = Volume Controlled Ventilation

PCV = Pressure Controlled Ventilation

VCV is a ventilation mode with a set tidal volume. Its the ventilation mode mostly used in the operating room. The tidal volume will be delivered independent of the pressure (up to the setting of the pressure relief valve). The danger of VCV is barotrauma in patients at risk (i.e. patients with ARDS or COPD).

PCV is a ventilation mode with a set maximal peak airway pressure. It might be used in patients with diseases such as ARDS or bronchopleural fistula. The danger of PCV is decreased minute ventilation during episodes of high airway pressures (asthma, obstruction of endotracheal tube,...).

 

 

back to question 1 click here


© Internet Scientific Publications, L.L.C., 1996 to 1999.

First Published: October 1996

The Internet Journal of Anesthesiology